YAR SAĞLAM, A. S. Et Al. 2016. HDAC inhibitors MS 275 and salermide potentiates the anticancer effect of EF24 in human pancreatic cancer cells. 6. Multidisipliner Kanser Araştırma Kongresi .

YAR SAĞLAM, A. S., YILMAZ, A., ÖNEN, H. İ., ALP, E., KAYHAN, H., & EKMEKÇİ, A., (2016). HDAC inhibitors MS 275 and salermide potentiates the anticancer effect of EF24 in human pancreatic cancer cells . 6. Multidisipliner Kanser Araştırma Kongresi

YAR SAĞLAM, ATİYE Et Al. "HDAC inhibitors MS 275 and salermide potentiates the anticancer effect of EF24 in human pancreatic cancer cells," 6. Multidisipliner Kanser Araştırma Kongresi, 2016

YAR SAĞLAM, ATİYE S. Et Al. "HDAC inhibitors MS 275 and salermide potentiates the anticancer effect of EF24 in human pancreatic cancer cells." 6. Multidisipliner Kanser Araştırma Kongresi , 2016

YAR SAĞLAM, A. S. Et Al. (2016) . "HDAC inhibitors MS 275 and salermide potentiates the anticancer effect of EF24 in human pancreatic cancer cells." 6. Multidisipliner Kanser Araştırma Kongresi .

@conferencepaper{conferencepaper, author={ATİYE SEDA YAR SAĞLAM Et Al. }, title={HDAC inhibitors MS 275 and salermide potentiates the anticancer effect of EF24 in human pancreatic cancer cells}, congress name={6. Multidisipliner Kanser Araştırma Kongresi}, city={}, country={}, year={2016}}